Related Experiment Video

Updated: Jun 1, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

Severity of ICU-acquired pneumonia according to infectious microorganisms

Pierre Damas1, Nathalie Layios, Laurence Seidel

  • 1Department of General Intensive Care, University Hospital of Liege, University of Liege, Domaine Universitaire de Liège, 4000, Liege, Belgium. pdamas@chu.ulg.ac.be

Intensive Care Medicine
|May 27, 2011
PubMed
Abstract

Insights

Intensive care unit (ICU)-acquired pneumonia (ICUAP) severity is linked to patient health before infection, not the specific bacteria. ICUAP severity, however, directly impacts ICU mortality.

Area of Science:

  • Critical Care Medicine
  • Infectious Diseases
  • Pulmonology

Background:

  • Intensive care unit-acquired pneumonia (ICUAP) is a significant complication in critically ill patients.
  • Understanding factors influencing ICUAP severity is crucial for patient management and outcomes.
  • Previous studies have explored various risk factors, but the specific role of bacterial type requires further clarification.

Purpose of the Study:

  • To evaluate the severity of ICU-acquired pneumonia (ICUAP) based on the causative bacterial classification.
  • To determine the contribution of ICUAP to overall organ dysfunction during ICU stay.
  • To identify risk factors for sepsis severity and mortality in ICUAP patients.

Main Methods:

  • A prospective study involving 453 adult patients with ICUAP over a 4-year period.
  • Daily Sequential Organ Failure Assessment (SOFA) scores were recorded.
  • ICUAP severity was assessed by sepsis severity and the development of new organ dysfunctions or failures (OD/F).

Main Results:

  • The occurrence of new organ dysfunctions/failures during ICUAP was similar across different bacterial types.
  • Pre-ICUAP organ dysfunction (SOFApreICUAP) was significantly associated with ICUAP severity.
  • Bacterial type was not a risk factor for septic shock or mortality; age and SOFApreICUAP were risk factors for sepsis severity, while ICUAP severity was a risk factor for ICU mortality.

Conclusions:

  • ICUAP contributes minimally to the overall organ dysfunction experienced during an ICU stay.
  • ICUAP severity is primarily determined by the patient's pre-existing clinical condition, not the specific infecting bacteria.
  • The severity of ICUAP is a direct determinant of ICU mortality.

More Related Videos

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii09:17

A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii

Published on: January 2, 2017

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia04:32

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Published on: June 28, 2018

Related Concept Videos

Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...